Genpharmasec share news, announcements and annual reports
BSE: 531592Commercial Services & SuppliesSmall Cap
GENPHARMASEC LIMITED · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Apr 1996
Last close ₹1.02up ₹0.03 (3.03%)
Share price at the BSE close on 2 Nov 2026. Previous close ₹0.99.
2 Nov: open ₹1.00, high ₹1.03, low ₹0.98
52-week range of traded prices to 2 Nov 2026
₹0.75Low, 30 Mar 2026₹1.79High, 3 Nov 2025
- Next results date: the board meets on 3 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹56 Cr3,222nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.85
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −1.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.50
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 3,52,702
Genpharmasec board meetings
162 filed, newest first. Page 1 of 4.
Oct 2026
29 Oct · Board meeting
Meeting on 3 Nov 2026: quarterly results
Sep 2026
Aug 2026
28 Aug · Board meeting
Meeting on 2 Sep 2026: annual general meeting3 Aug · Board meeting
Meeting on 11 Aug 2026: quarterly results
May 2026
13 May · Board meeting
Meeting on 21 May 2026: audited results
Feb 2026
2 Feb · Board meeting
Meeting on 9 Feb 2026: quarterly results
Oct 2025
27 Oct · Board meeting
Meeting on 6 Nov 2025: quarterly results
Sep 2025
2 Sep · Board meeting
Aug 2025
28 Aug · Board meeting
Meeting on 2 Sep 2025: annual general meeting1 Aug · Board meeting
Meeting on 7 Aug 2025: quarterly results
May 2025
21 May · Board meeting
13 May · Board meeting
Meeting on 21 May 2025: audited results
Mar 2025
Feb 2025
3 Feb · Board meeting
Meeting on 10 Feb 2025: quarterly results
Nov 2024
5 Nov · Board meeting
Meeting on 12 Nov 2024: quarterly results
Aug 2024
13 Aug · Board meeting
6 Aug · Board meeting
Meeting on 13 Aug 2024: quarterly results
Jun 2024
24 Jun · Board meeting
Meeting on 27 Jun 2024: annual general meeting
May 2024
24 May · Board meeting
14 May · Board meeting
Meeting on 24 May 2024: audited results
Mar 2024
21 Mar · Board meeting
Meeting on 27 Mar 202420 Mar · Board meeting
Meeting on 26 Mar 2024
Feb 2024
12 Feb · Board meeting
12 Feb · Board meeting
5 Feb · Board meeting
Meeting on 12 Feb 2024: quarterly results
Nov 2023
1 Nov · Board meeting
Meeting on 8 Nov 2023: quarterly results
Aug 2023
3 Aug · Board meeting
Meeting on 11 Aug 2023: quarterly results